{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:19:17Z","timestamp":1784866757759,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFAG 10465"],"award-info":[{"award-number":["MFAG 10465"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5310-4","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T09:03:48Z","timestamp":1548925428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review"],"prefix":"10.1186","volume":"19","author":[{"given":"Ersilia","family":"Lucenteforte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Vannacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Crescioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cetica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Coniglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bonaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Messeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Barale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mugelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-7214","authenticated-orcid":false,"given":"Valentina","family":"Maggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"5310_CR1","unstructured":"World Health Organization. Cancer Pain Relief \u2013 with a guide to opioid availability 1996."},{"key":"5310_CR2","unstructured":"World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses 2012."},{"issue":"6","key":"5310_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.clon.2011.04.015","volume":"23","author":"J Droney","year":"2011","unstructured":"Droney J, Riley J, Ross JR. Evolving knowledge of opioid genetics in cancer pain. Clin Oncol. 2011;23(6):418\u201328.","journal-title":"Clin Oncol"},{"issue":"13\u201314","key":"5310_CR4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.clinbiochem.2014.05.065","volume":"47","author":"BM Kapur","year":"2014","unstructured":"Kapur BM, Lala PK, Shaw JL. Pharmacogenetics of chronic pain management. Clin Biochem. 2014;47(13\u201314):1169\u201387.","journal-title":"Clin Biochem"},{"issue":"7","key":"5310_CR5","first-page":"330","volume":"69","author":"AA Esch van","year":"2011","unstructured":"van Esch AA, de Vries E, Te Morsche RH, van Oijen MG, Jansen JB, Drenth JP. Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis. Neth J Med. 2011;69(7):330\u20134.","journal-title":"Neth J Med"},{"issue":"1","key":"5310_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuroimage.2005.05.030","volume":"28","author":"A Berthele","year":"2005","unstructured":"Berthele A, Platzer S, Jochim B, Boecker H, Buettner A, Conrad B, Riemenschneider M, Toelle TR. COMT Val108\/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression. NeuroImage. 2005;28(1):185\u201393.","journal-title":"NeuroImage"},{"issue":"7","key":"5310_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/nan.12219","volume":"41","author":"J Moskovitz","year":"2015","unstructured":"Moskovitz J, Walss-Bass C, Cruz DA, Thompson PM, Hairston J, Bortolato M. The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val\/met allele-dependent fashion. Neuropathol Appl Neurobiol. 2015;41(7):941\u201351.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"5310_CR8","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.pain.2014.09.009","volume":"155","author":"SB Smith","year":"2014","unstructured":"Smith SB, Reenil\u00e4 I, M\u00e4nnist\u00f6 PT, Slade GD, Maixner W, Diatchenko L, Nackley AG. Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain. Pain. 2014;155(11):2390\u20139.","journal-title":"Pain"},{"issue":"5610","key":"5310_CR9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.1078546","volume":"299","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299(5610):1240\u20133.","journal-title":"Science"},{"issue":"7","key":"5310_CR10","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.1002\/brb3.471","volume":"6","author":"GP Kurita","year":"2016","unstructured":"Kurita GP, Ekholm O, Kaasa S, Klepstad P, Skorpen F, Sjogren P. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer. Brain behav. 2016;6(7):e00471.","journal-title":"Brain behav"},{"key":"5310_CR11","volume-title":"GLOBOCAN-estimated cancer incidence, Mortality and prevalence worldwide","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. GLOBOCAN-estimated cancer incidence, Mortality and prevalence worldwide 2012."},{"issue":"1","key":"5310_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","volume":"125","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229\u201334.","journal-title":"Int J Cancer"},{"issue":"1","key":"5310_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12885-018-4478-3","volume":"18","author":"E Lucenteforte","year":"2018","unstructured":"Lucenteforte E, Vagnoli L, Pugi A, Crescioli G, Lombardi N, Bonaiuti R, Aric\u00f2 M, Giglio S, Messeri A, Mugelli A, et al. A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study. BMC Cancer. 2018;18(1):568.","journal-title":"BMC Cancer"},{"key":"5310_CR14","unstructured":"Eastern Metropolitan Region Palliative Care Consortium (Victoria) Clinical Group. Opioid Conversion Ratios \u2013 Guide to Practice 2013. Available at: \n                    http:\/\/www.emrpcc.org.au\/wp-content\/uploads\/2013\/10\/EMRPCC-Opioid-Conversion-2013-final.pdf\n                    \n                  . Accessed 24 Jan 2019."},{"key":"5310_CR15","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1, 2011. Available at: \n                    http:\/\/handbook-5-1.cochrane.org\/\n                    \n                  . Accessed 24 Jan 2019."},{"key":"5310_CR16","unstructured":"National Heart L aBIN. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Available at: \n                    https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools\n                    \n                   [Accessed 04 Apr 2018]."},{"issue":"7571","key":"5310_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR, et al. The 1000 genomes project consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"5","key":"5310_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","volume":"152","author":"P Klepstad","year":"2011","unstructured":"Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundstrom S, Maltoni M, et al. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain. 2011;152(5):1139\u201345.","journal-title":"Pain"},{"issue":"4","key":"5310_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/FPC.0000000000000032","volume":"24","author":"DT Barratt","year":"2014","unstructured":"Barratt DT, Bandak B, Klepstad P, Dale O, Kaasa S, Christrup LL, Tuke J, Somogyi AA. Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenet Genomics. 2014;24(4):185\u201394.","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"5310_CR20","doi-asserted-by":"publisher","first-page":"e0137179","DOI":"10.1371\/journal.pone.0137179","volume":"10","author":"DT Barratt","year":"2015","unstructured":"Barratt DT, Klepstad P, Dale O, Kaasa S, Somogyi AA. Innate immune Signalling genetics of Pain, cognitive dysfunction and sickness symptoms in Cancer Pain patients treated with transdermal fentanyl. PLoS One. 2015;10(9):e0137179.","journal-title":"PLoS One"},{"issue":"11","key":"5310_CR21","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","volume":"47","author":"EA Laugsand","year":"2011","unstructured":"Laugsand EA, Fladvad T, Skorpen F, Maltoni M, Kaasa S, Fayers P, Klepstad P. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. Eur J Cancer. 2011;47(11):1682\u201391.","journal-title":"Eur J Cancer"},{"issue":"5","key":"5310_CR22","first-page":"1393","volume":"27","author":"H Matsuoka","year":"2012","unstructured":"Matsuoka H, Arao T, Makimura C, Takeda M, Kiyota H, Tsurutani J, Fujita Y, Matsumoto K, Kimura H, Otsuka M, et al. Expression changes in arrestin beta 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. Oncol Rep. 2012;27(5):1393\u20139.","journal-title":"Oncol Rep"},{"issue":"1\u20132","key":"5310_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","volume":"116","author":"TT Rakvag","year":"2005","unstructured":"Rakvag TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain. 2005;116(1\u20132):73\u20138.","journal-title":"Pain"},{"key":"5310_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1744-8069-4-64","volume":"4","author":"TT Rakvag","year":"2008","unstructured":"Rakvag TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain. 2008;4:64.","journal-title":"Mol Pain"},{"issue":"5","key":"5310_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","volume":"5","author":"JR Ross","year":"2005","unstructured":"Ross JR, Rutter D, Welsh K, Joel SP, Goller K, Wells AU, Du Bois R, Riley J. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J. 2005;5(5):324\u201336.","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"5310_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.therap.2016.04.004","volume":"71","author":"I Chatti","year":"2016","unstructured":"Chatti I, Creveaux I, Woillard JB, Langlais S, Amara A, Ben Fatma L, Saad A, Gribaa M, Libert F. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: impact of the high genetic heterogeneity in Tunisia? Therapie. 2016;71(5):507\u201313.","journal-title":"Therapie"},{"issue":"1\u20132","key":"5310_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pain.2006.10.023","volume":"130","author":"CC Reyes-Gibby","year":"2007","unstructured":"Reyes-Gibby CC, Shete S, Rakvag T, Bhat SV, Skorpen F, Bruera E, Kaasa S, Klepstad P. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. 2007;130(1\u20132):25\u201330.","journal-title":"Pain"},{"issue":"6","key":"5310_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/cncr.23292","volume":"112","author":"JR Ross","year":"2008","unstructured":"Ross JR, Riley J, Taegetmeyer AB, Sato H, Gretton S, du Bois RM, Welsh KI. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer. 2008;112(6):1390\u2013403.","journal-title":"Cancer"},{"issue":"9","key":"5310_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/FPC.0b013e3283560c46","volume":"22","author":"A Tammimaki","year":"2012","unstructured":"Tammimaki A, Mannisto PT. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genomics. 2012;22(9):673\u201391.","journal-title":"Pharmacogenet Genomics"},{"key":"5310_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-381326-8.00010-7","volume":"95","author":"O Kambur","year":"2010","unstructured":"Kambur O, Mannisto PT. Catechol-O-methyltransferase and pain. Int Rev Neurobiol. 2010;95:227\u201379.","journal-title":"Int Rev Neurobiol"},{"key":"5310_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fnbeh.2014.00409","volume":"8","author":"CM Chau","year":"2014","unstructured":"Chau CM, Ranger M, Sulistyoningrum D, Devlin AM, Oberlander TF, Grunau RE. Neonatal pain and COMT Val158Met genotype in relation to serotonin transporter (SLC6A4) promoter methylation in very preterm children at school age. Front Behav Neurosci. 2014;8:409.","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"5310_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/FTD.0000000000000301","volume":"38","author":"L Elens","year":"2016","unstructured":"Elens L, Norman E, Matic M, Rane A, Fellman V, van Schaik RH. Genetic predisposition to poor opioid response in preterm infants: impact of KCNJ6 and COMT polymorphisms on Pain relief after endotracheal intubation. Ther Drug Monit. 2016;38(4):525\u201333.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"5310_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1213\/ANE.0b013e31826f0637","volume":"116","author":"C Mamie","year":"2013","unstructured":"Mamie C, Rebsamen MC, Morris MA, Morabia A. First evidence of a polygenic susceptibility to pain in a pediatric cohort. Anesth Analg. 2013;116(1):170\u20137.","journal-title":"Anesth Analg"},{"issue":"10","key":"5310_CR34","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2217\/pgs.14.100","volume":"15","author":"M Matic","year":"2014","unstructured":"Matic M, Simons SH, van Lingen RA, van Rosmalen J, Elens L, de Wildt SN, Tibboel D, van Schaik RH. Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype. Pharmacogenomics. 2014;15(10):1287\u201395.","journal-title":"Pharmacogenomics"},{"issue":"2","key":"5310_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/art.24175","volume":"60","author":"JB Meurs van","year":"2009","unstructured":"van Meurs JB, Uitterlinden AG, Stolk L, Kerkhof HJ, Hofman A, Pols HA, Bierma-Zeinstra SM. A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum. 2009;60(2):628\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5310_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/hmg\/ddi013","volume":"14","author":"L Diatchenko","year":"2005","unstructured":"Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14(1):135\u201343.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5310_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-3476(99)70326-4","volume":"135","author":"A Hunt","year":"1999","unstructured":"Hunt A, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr. 1999;135(1):47\u201355.","journal-title":"J Pediatr"},{"issue":"6","key":"5310_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00228-015-1843-x","volume":"71","author":"MI Altamimi","year":"2015","unstructured":"Altamimi MI, Choonara I, Sammons H. Inter-individual variation in morphine clearance in children. Eur J Clin Pharmacol. 2015;71(6):649\u201355.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5310_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pds.2063","volume":"20","author":"T Lasky","year":"2011","unstructured":"Lasky T, Ernst FR, Greenspan J, Wang S, Gonzalez L. Estimating pediatric inpatient medication use in the United States. Pharmacoepidemiol Drug Saf. 2011;20(1):76\u201382.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"5310_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1542\/hpeds.2014-0084","volume":"5","author":"SJ Friedrichsdorf","year":"2015","unstructured":"Friedrichsdorf SJ, Postier A, Eull D, Weidner C, Foster L, Gilbert M, Campbell F. Pain outcomes in a US Children's hospital: a prospective cross-sectional survey. Hospital pediatrics. 2015;5(1):18\u201326.","journal-title":"Hospital pediatrics"},{"issue":"5","key":"5310_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/0269216310384902","volume":"25","author":"O Dale","year":"2011","unstructured":"Dale O, Moksnes K, Kaasa S. European palliative care research collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med. 2011;25(5):494\u2013503.","journal-title":"Palliat Med"},{"issue":"1","key":"5310_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","volume":"75","author":"AM Drewes","year":"2013","unstructured":"Drewes AM, Jensen RD, Nielsen LM, Droney J, Christrup LL, Arendt-Nielsen L, Riley J, Dahan A. Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol. 2013;75(1):60\u201378.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5310_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jpainsymman.2009.06.004","volume":"38","author":"PE Shaheen","year":"2009","unstructured":"Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manag. 2009;38(3):409\u201317.","journal-title":"J Pain Symptom Manag"},{"issue":"12","key":"5310_CR44","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.jpain.2015.09.005","volume":"16","author":"JA Rabbitts","year":"2015","unstructured":"Rabbitts JA, Palermo TM, Zhou C, Mangione-Smith R. Pain and Health-related quality of life after pediatric inpatient surgery. J Pain. 2015;16(12):1334\u201341.","journal-title":"J Pain"},{"issue":"1","key":"5310_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4037\/ajcc2010624","volume":"19","author":"T Voepel-Lewis","year":"2010","unstructured":"Voepel-Lewis T, Zanotti J, Dammeyer JA, Merkel S. Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients. Am J Crit Care. 2010;19(1):55\u201361 quiz 62.","journal-title":"Am J Crit Care"},{"issue":"1","key":"5310_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1553-2712.2009.00620.x","volume":"17","author":"G Garra","year":"2010","unstructured":"Garra G, Singer AJ, Taira BR, Chohan J, Cardoz H, Chisena E, Thode HC Jr. Validation of the Wong-Baker FACES Pain rating scale in pediatric emergency department patients. Acad Emerg Med Off J Soc Acad Emerg Med. 2010;17(1):50\u20134.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5310-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T19:09:25Z","timestamp":1580411365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5310-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5310"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5310-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The STOP Pain study obtained ethics approval from the institutional review board at Meyer Children\u2019s Hospital (Protocol letter 9116\/2010, December 14, 2010). Written informed consent to participate in the study was obtained from each patient (or their parent or legal guardian).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"113"}}